11.20
-0.9(-7.44%)
Currency In USD
| Previous Close | 12.1 |
| Open | 11.67 |
| Day High | 11.67 |
| Day Low | 10.98 |
| 52-Week High | 21.95 |
| 52-Week Low | 4.5 |
| Volume | 52,146 |
| Average Volume | 58,504 |
| Market Cap | 45.29M |
| PE | -0.52 |
| EPS | -21.61 |
| Moving Average 50 Days | 8.31 |
| Moving Average 200 Days | 9.41 |
| Change | -0.9 |
If you invested $1000 in FibroGen, Inc. (FGEN) 10 years ago, it would be worth $17.07 as of September 08, 2025 at a share price of $11.2. Whereas If you bought $1000 worth of FibroGen, Inc. (FGEN) shares 5 years ago, it would be worth $10.63 as of September 08, 2025 at a share price of $11.2.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million
GlobeNewswire Inc.
Sep 02, 2025 11:00 AM GMT
Total consideration for the sale of FibroGen China to AstraZeneca is approximately $220 million, a $60 million increase from initial guidanceSuccessfully repaid term loan to Morgan Stanley Tactical Value, further simplifying the Company’s capital str
FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire Inc.
Aug 27, 2025 8:02 PM GMT
SAN FRANCISCO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the H.C. Wainwright 27th Annual Global Investment Conference being held September 8-10, 2025, in New
FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation
GlobeNewswire Inc.
Aug 18, 2025 11:00 AM GMT
Sale of FibroGen China remains on track to close in 3Q 2025 SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the China State Administration for Market Regulation approved the sale of FibroGen Inter